Skip to main content
SpringerLink
Log in

Surveillance After Gastric Resection

  • Chapter
  • First Online:
Book cover Gastric Cancer

Abstract

After curative gastrectomy, recurrence occurs in a significant proportion of patients and this is inexorably associated with poor outcome in almost all cases. Still there is currently no consensus on the best strategy for surveilling patients who have undergone surgical treatment for gastric cancer.

Considering the poor survival of patients with recurrent gastric cancer and until effective treatments for most patterns of recurrence will be not available, the benefit of early detection of recurrence seems questionable. The wide variation in recommendations for surveillance among international experts and hospital schedules clearly reflects a lack of reliable quality data on this topic. As a consequence most of the international guidelines gloss over details on the mode, duration, and intensity of surveillance, since they cannot be based on an acceptable grade of recommendation.

In recent years an increasing focus on evidence-based medicine, which has coincided with growing concern about costs and efficiency in medicine, has caused a reevaluation of most surveillance practices. In this chapter current evidences and follow-up practices after curative resection of gastric cancer are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi57–63

    Article  PubMed  Google Scholar 

  2. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D’Amico TA, Das P, et al. NCCN gastric cancer panel: gastric cancer. J Natl Compr Canc Netw. 2010;8:378–409.

    CAS  PubMed  Google Scholar 

  3. Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ. 2002;324(7341):813.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG 3rd, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080–2.

    CAS  PubMed  Google Scholar 

  5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  6. Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer. 2000;89:255–61.

    Article  CAS  PubMed  Google Scholar 

  7. Katai H, Maruyama K, Sasako M, Sano T, Okajima K, Kinoshita T, et al. Mode of recurrence after gastric cancer surgery. Dig Surg. 1994;11:99–103.

    Article  Google Scholar 

  8. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10:898–902.

    Article  PubMed  Google Scholar 

  9. Whiting J, Sano T, Saka M, Fukagawa T, Katai H, Sasako M. Follow-up of gastric cancer: a review. Gastric Cancer. 2006;9:74–81.

    Article  PubMed  Google Scholar 

  10. Böhner H, Zimmer T, Hopfenmüller W, Berger G, Buhr HJ. Detection and prognosis of recurrent gastric cancer is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 2000;47:1489–94.

    PubMed  Google Scholar 

  11. Tan IT, So BY. Value of intensive follow-up of patients after curative surgery for gastric carcinoma: J Surg Oncol. 2007;96:503–6.

    Article  PubMed  Google Scholar 

  12. Mikani K, Yamashita Y, Maekawa T, Shinohara T, Yamauchi Y, Hoshino S, et al. Surveillance program for recurrence after curative gastric cancer surgery. Chir Gastroenterol. 2007;23:392–8

    Article  Google Scholar 

  13. Bennett JJ, Gonen M, D’Angelica M, Jaques DP, Brennan MF, Coit DG. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg. 2005;201:503–10.

    Article  PubMed  Google Scholar 

  14. Kim JH, Jang YJ, Park SS, Park SH, Mok YJ. Benefit of post-operative surveillance for recurrence after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:969–76.

    Article  PubMed  Google Scholar 

  15. Bilici A, Salman T, Oven Ustaalioglu BB, Unek T, Seker M, Aliustaoglu M, et al. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy. J Surg Res. 2013;180:1–9

    Article  Google Scholar 

  16. Cardoso R, Coburn NG, Seevaratnam R, Mahar A, Helyer L, Law C, et al. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer. 2012;15(Suppl 1):164–7.

    Article  Google Scholar 

  17. Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.

    Article  Google Scholar 

  18. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R, Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449–72.

    Article  CAS  PubMed  Google Scholar 

  19. Marrelli D, Morgagni P, de Manzoni G, Coniglio A, Marchet A, Saragoni L, et al. Italian Research Group for Gastric Cancer (IRGGC). Prediction of recurrence after radical surgery for gastric cancer. A scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–55.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Eom BW, Yoon H, Ryu KW, Lee JH, Cho SJ, Lee JY, et al. Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg. 2010;27:481–6.

    Article  PubMed  Google Scholar 

  21. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236–42.

    Article  CAS  PubMed  Google Scholar 

  22. Salem A, Hashem S, Mula-Hussain LY, Mohammed I, Nour A, Shelpai W, et al. Management strategies for locoregional recurrence in early-stage gastric cancer: retrospective analysis and comprehensive literature review. J Gastrointest Cancer 2012;43:77–82.

    Article  PubMed  Google Scholar 

  23. Tersmette AC, Offerhaus GJ, Tersmette KW, Giardiello FM, Moore GW, Tytgat GN, et al. Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res. 1990;50:6486–9.

    CAS  PubMed  Google Scholar 

  24. Lundegardh G, Adami HO, Helmick C, Zack M, Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med. 1988;319:195–200.

    Article  CAS  PubMed  Google Scholar 

  25. Nozaki I, Nasu J, Kubo Y, Tanada M, Nishimura R, Kurita A. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg. 2010;34:1548–54.

    Article  PubMed  Google Scholar 

  26. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003;133:507–11.

    Article  PubMed  Google Scholar 

  27. Jensen EH, Tuttle TM. Preoperative staging and postoperative surveillance for gastric cancer. Surg Oncol Clin N Am. 2007;16:329–42.

    Article  PubMed  Google Scholar 

  28. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer. Cancer. 1993;72:37–41.

    Article  CAS  PubMed  Google Scholar 

  29. Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjodén PO, Haglund U, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8:163–8.

    Article  CAS  PubMed  Google Scholar 

  30. Pyrhoenen S, Kuitunen T, Nyandoto P, Kouri M. Randomized comparison of 5-fluorouracil, epidoxorubicin, and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71:587–91.

    Article  Google Scholar 

  31. Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndrome. Surg Clin North Am. 1992;72:445–65.

    CAS  PubMed  Google Scholar 

  32. Kim HI, Hyung WJ, Song KJ, Choi SH, Kim CB, Noh SH. Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol. 2011;18:3711–7.

    Article  PubMed  Google Scholar 

  33. Tovey FI, Hall ML, Ell PJ, Hobsley M. Postgastrectomy osteoporosis. Br J Surg. 1991;78:1335–7.

    Article  CAS  PubMed  Google Scholar 

  34. Tovey FI, Hobsley M. Post-gastrectomy patients need to be followed up for 20–30 years. World J Gastroenterol. 2000;6:45–8.

    PubMed  Google Scholar 

  35. Bae JM, Park JW, Yang HK, Kim JP. Nutritional status of gastric cancer patients after total gastrectomy. World J Surg. 1998;22:254–60.

    Article  CAS  PubMed  Google Scholar 

  36. Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F. Clinical utility of CEA, CA 19- 9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg. 2001;181:16–9.

    Article  CAS  PubMed  Google Scholar 

  37. Patriti A, Graziosi L, Baffa N, Pacifico E, Lamprini P, Valiani S, et al. Postoperative follow-up of gastric adenocarcinoma with neoplastic markers and 18-FDG-PET/CT. Ann Ital Chir. 2007;78:481–5.

    PubMed  Google Scholar 

  38. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142–5.

    Article  PubMed  Google Scholar 

  39. Ikeda Y, Mori M, Kajiyama K, Kamakura T, Maehara Y, Haraguchi Y, et al. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer. Hepatogastroenterology. 1996;43:1281–7.

    CAS  PubMed  Google Scholar 

  40. Choi SR, Jang JS, Lee JH, Roh MH, Kim MC, Lee WS, et al. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci. 2006;51:2081–6.

    Article  CAS  PubMed  Google Scholar 

  41. Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology. 2002;49:1157–60.

    PubMed  Google Scholar 

  42. Kim KW, Choi BI, Han JK, Kim TK, Kim AY, Lee HJ, et al. Postoperative anatomic and pathologic findings at CT following gastrectomy. Radiographics. 2002;22:323–36.

    Article  PubMed  Google Scholar 

  43. Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003;58:215–21.

    Article  CAS  PubMed  Google Scholar 

  44. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology. 2002;224:748–56.

    Article  PubMed  Google Scholar 

  45. Stahl A, Ott K, Weber WA, Fink U, Siewert JR, Schwaiger M. Correlation of FDG uptake in gastric carcinomas with endoscopic and histopathological findings. J Nucl Med. 2001;42:78P–9P.

    Google Scholar 

  46. Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging. 2009;34:441–7.

    Article  PubMed  Google Scholar 

  47. Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, et al. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol. 2008;14:4627–32.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Sim SH, Kim YJ, Oh DY, Lee SH, Kim DW, Kang WJ, et al. The role of PET/CT in detection of gastric cancer recurrence. BMC Cancer. 2009;9:73.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Ozkan E, Araz M, Soydal C, Kucuk ON. The role of 18F-FDG-PET/CT in the preoperative staging and post-therapy follow up of gastric cancer: comparison with spiral CT. World J Surg Onc. 2011;9:75.

    Article  Google Scholar 

  50. Baiocchi GL, Marrelli D, Verlato G, Morgagni P, Giacopuzzi S, Coniglio A, et al. Follow-up after gastrectomy for cancer: An appraisal of the Italian research group for gastric cancer. Ann Surg Oncol. 2014;21(6):2005–11 (Epub Feb 14 2014).

    PubMed  Google Scholar 

  51. Meyers MA, McSweeney J. Secondary neoplasms of the bowel. Radiology. 1972;105:1–11.

    Article  CAS  PubMed  Google Scholar 

  52. Inoue K, Nakane Y, Michiura T, Yamaki S, Yui R, Sakuramoto K, et al. Feasibility and accuracy of second look laparoscopy after gastrectomy for gastric cancer. Surg Endosc. 2009;23:2307–13.

    Article  PubMed  Google Scholar 

  53. Lee SY, Lee JH, Hwang NC, Kim YH, Rhee PL, Kim JJ, et al. The role of follow-up endoscopy after total gastrectomy for gastric cancer. Eur J Surg Oncol. 2005;31:265–9.

    Article  PubMed  Google Scholar 

  54. Fujita T, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T. Relationship between the histological type of initial lesions and the risk for the development of remnant gastric cancers after gastrectomy for synchronous multiple gastric cancers. World J Surg. 2010;34:296–302.

    Article  PubMed  Google Scholar 

  55. Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg. 2007;94:92–5.

    Article  CAS  PubMed  Google Scholar 

  56. Greene FL. Management of gastric remnant carcinoma based on the results of a 15-year endoscopic screening program. Ann Surg. 1996;223:701–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Kikuchi S, Sato M, Katada N, Sakuramoto S, Shimao H, Kakita A, et al. Efficacy of endoscopic surveillance of the upper gastrointestinal tract following distal gastrectomy for early gastric cancer. Hepatogastroenterology. 2003;50:1704–7.

    PubMed  Google Scholar 

  58. Kato M, Nishida T, Yamamoto K, Hayashi S, Kitamura S, Yabuta T, et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut. 2013;62:1425–32

    Article  PubMed  Google Scholar 

  59. Sibbald B, Roland M. Understanding controlled trials: why are randomised controlled trials important? BMJ. 1998;316:201

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  60. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376–8

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, “A. Gemelli” Hospital, University Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00167, Rome, Italy

    Domenico D’Ugo MD, FACS

  2. Department of Surgery, Catholic University of Rome, Policlinico Agostino Gemelli, Rome, Italy

    Alberto Biondi MD & Andrea Tufo MD

  3. Department of Surgery, Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy

    Gianluca Baiocchi MD

  4. Department of Surgical Sciences (Pathology), “A. Gemelli” University Hospital, Catholic University of Rome, Rome, Italy

    Roberto Persiani MD

Authors
  1. Domenico D’Ugo MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Biondi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Tufo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gianluca Baiocchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberto Persiani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico D’Ugo MD, FACS .

Editor information

Editors and Affiliations

  1. Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Vivian E. Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

D’Ugo, D., Biondi, A., Tufo, A., Baiocchi, G., Persiani, R. (2015). Surveillance After Gastric Resection. In: Strong, V. (eds) Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-15826-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15826-6_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15825-9

  • Online ISBN: 978-3-319-15826-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation